BDRX

About Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) Stock

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) closed the 2026-09-17 session at $0.80, down 16.67% versus the previous close (-0.16). The stock opened at $0.87 and traded between $0.72 and $0.95 during that session. Session trading volume was 1.3M shares. The volume-weighted average price (VWAP) is $0.83.

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals plc American Depositary Shs has a market capitalization of $987,903.36. BDRX is listed on the XNAS exchange. The company employs approximately 11 people. The recorded listing date is 2015-12-07.

On this page you can find market BDRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.